Substance
INSULIN GLARGINE
Global reference: every product and company linked to this substance.
- cas: 160337-95-1
- ncit: C47564
- pubchem_cid: 118984454
- rxnorm: 274783
- unii: 2ZM8CX04RZ
BASAGLAR · BASAGLAR COMPONENT INSULIN GLARGINE · HOE 71GT · HOE-71GT · HOE-901 · HOE901 · insulin glargine [INN] · INSULIN GLARGINE [JAN] · INSULIN GLARGINE [USAN] · Insulin glargine [WHO-DD] · LANTUS · LANTUS R
Revenue by product (2)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| ELI LILLY AND COMPANY COMMON STOCK | BASAGLAR | Q4 2024 | $853.8M |
| ELI LILLY AND COMPANY COMMON STOCK | BASAGLAR | Q4 2024 | $853.8M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (10)
- BASAGLAR · ELI LILLY AND COMPANY COMMON STOCK
- BASAGLAR · ELI LILLY AND COMPANY COMMON STOCK
- LANTUS · SANOFI ADS
- LANTUS SOLOSTAR · SANOFI ADS
- LANTUS · SANOFI ADS
- SEMGLEE · VIATRIS INC. COMMON STOCK
- SOLIQUA 100/33 · SANOFI ADS
- SEMGLEE · VIATRIS INC. COMMON STOCK
- TOUJEO MAX SOLOSTAR · SANOFI ADS
- TOUJEO SOLOSTAR · SANOFI ADS